Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS other · 2016-11-01

Clinical Trial Update: Dexmedetomidine for the Treatment of Delirium After Heart Surgery [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating dexmedetomidine for postoperative delirium after heart surgery has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dexmedetomidine (Dexmedetomidine)

Snippet

Sponsor: Thorax-Kärlkliniken | Conditions: Postoperative, Delirium | Phase 3 | Status: TERMINATED